Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2021 Filed Aug 5, 2021 21:03 UTC |
Bruehlman Ronald ESee Remarks
|
Tax withholdingCommon Stock | 2,391 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000052 · wf-form4_162819736861943.xml · nonDerivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,047 Read SEC document |
| July 20, 2021 Filed Feb 14, 2022 22:06 UTC |
Bruehlman Ronald ESee Remarks
|
PurchaseCommon Stock | 13 | $245.32 | $3,189.16 |
DisclosureSEC source: 0001478242-22-000022 · wf-form4_164487637172562.xml · nonDerivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,355 Read SEC document |
| July 14, 2021 Filed Dec 23, 2021 22:14 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 111 | $246.00 | $27,306.00 |
DisclosureSEC source: 0001478242-21-000064 · wf-form4_164029764106187.xml · derivative · entry 5 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 389 Underlying: Common Stock · 111 shares Expires not disclosed F4 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F4 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F4 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| July 14, 2021 Filed Feb 2, 2022 22:01 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 117 | $246.00 | $28,782.00 |
DisclosureSEC source: 0001478242-22-000005 · wf-form5_164383923231572.xml · derivative · entry 3 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,991 Underlying: Common Stock · 117 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 21:06 UTC |
DANHAKL JOHN GDirector
|
GrantCommon Stock | 934 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000038 · wf-form4_161886639755003.xml · nonDerivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 38,344 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. F2 · ownership.nature: Shares held in the Danhakl Revocable Family Trust. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 21:09 UTC |
Burt CarolDirector
|
GrantCommon Stock | 934 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000039 · wf-form4_161886653451920.xml · nonDerivative · entry 1 Burt Carol · CIK 0001493926 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 3,904 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. F2 · ownership.nature: Shares held in Carol Burt Hilliard Revocable Trust. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 21:05 UTC |
GOGGINS COLLEEN ADirector
|
GrantCommon Stock | 934 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000037 · wf-form4_161886630871291.xml · nonDerivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,185 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 21:04 UTC |
LEONARD JOHN MDirector
|
GrantCommon Stock | 934 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000036 · wf-form4_161886622846061.xml · nonDerivative · entry 1 LEONARD JOHN M · CIK 0001563584 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,678 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 21:02 UTC |
Rittenmeyer Ronald ADirector
|
GrantCommon Stock | 934 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000035 · wf-form4_161886613659160.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,828 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| April 15, 2021 Filed Dec 23, 2021 22:14 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 129 | $214.13 | $27,622.77 |
DisclosureSEC source: 0001478242-21-000064 · wf-form4_164029764106187.xml · derivative · entry 4 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278 Underlying: Common Stock · 129 shares Expires not disclosed F4 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F4 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F4 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| April 15, 2021 Filed Feb 2, 2022 22:01 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 134 | $214.13 | $28,693.42 |
DisclosureSEC source: 0001478242-22-000005 · wf-form5_164383923231572.xml · derivative · entry 2 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,874 Underlying: Common Stock · 134 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:40 UTC |
STAUB W RICHARDSee Remarks
|
GrantStock Appreciation Right · Derivative | 9,612 | $0.00 Strike: $183.82 | $0.00 |
DisclosureSEC source: 0001478242-21-000015 · wf-form4_161308321647666.xml · derivative · entry 4 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,612 Underlying: Common Stock · 9,612 shares Expires 2031-02-09 F3 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:40 UTC |
STAUB W RICHARDSee Remarks
|
Tax withholdingCommon Stock | 3,583 | $183.82 | $658,627.06 |
DisclosureSEC source: 0001478242-21-000015 · wf-form4_161308321647666.xml · nonDerivative · entry 3 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,094 Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:40 UTC |
STAUB W RICHARDSee Remarks
|
GrantCommon Stock | 2,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000015 · wf-form4_161308321647666.xml · nonDerivative · entry 2 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,677 F2 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 9, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:40 UTC |
STAUB W RICHARDSee Remarks
|
GrantCommon Stock | 9,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000015 · wf-form4_161308321647666.xml · nonDerivative · entry 1 STAUB W RICHARD · CIK 0001181162 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,270 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 8, 2018. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2021. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:26 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantStock Appreciation Right · Derivative | 96,124 | $0.00 Strike: $183.82 | $0.00 |
DisclosureSEC source: 0001478242-21-000011 · wf-form4_161308237461453.xml · derivative · entry 5 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,124 Underlying: Common Stock · 96,124 shares Expires 2031-02-09 F4 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:26 UTC |
BOUSBIB ARIDirector · See Remarks
|
Tax withholdingCommon Stock | 35,995 | $183.82 | $6,616,600.90 |
DisclosureSEC source: 0001478242-21-000011 · wf-form4_161308237461453.xml · nonDerivative · entry 3 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 652,095 Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:26 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantCommon Stock | 24,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000011 · wf-form4_161308237461453.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 688,090 F2 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 9, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:26 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantCommon Stock | 73,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000011 · wf-form4_161308237461453.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 664,015 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 8, 2018. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2021. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:20 UTC |
Sherbet EricSee Remarks
|
GrantStock Appreciation Right · Derivative | 8,544 | $0.00 Strike: $183.82 | $0.00 |
DisclosureSEC source: 0001478242-21-000010 · wf-form4_161308203651366.xml · derivative · entry 4 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,544 Underlying: Common Stock · 8,544 shares Expires 2031-02-09 F3 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:20 UTC |
Sherbet EricSee Remarks
|
Tax withholdingCommon Stock | 1,893 | $183.82 | $347,971.26 |
DisclosureSEC source: 0001478242-21-000010 · wf-form4_161308203651366.xml · nonDerivative · entry 3 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,692 Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:20 UTC |
Sherbet EricSee Remarks
|
GrantCommon Stock | 2,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000010 · wf-form4_161308203651366.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585 F2 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 9, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:20 UTC |
Sherbet EricSee Remarks
|
GrantCommon Stock | 5,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000010 · wf-form4_161308203651366.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,445 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 8, 2018. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2021. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:18 UTC |
Knightly Kevin CSee Remarks
|
GrantStock Appreciation Right · Derivative | 8,010 | $0.00 Strike: $183.82 | $0.00 |
DisclosureSEC source: 0001478242-21-000008 · wf-form4_161308189860018.xml · derivative · entry 4 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,010 Underlying: Common Stock · 8,010 shares Expires 2031-02-09 F3 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:18 UTC |
Knightly Kevin CSee Remarks
|
Tax withholdingCommon Stock | 3,745 | $183.82 | $688,405.90 |
DisclosureSEC source: 0001478242-21-000008 · wf-form4_161308189860018.xml · nonDerivative · entry 3 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,061 Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:18 UTC |
Knightly Kevin CSee Remarks
|
GrantCommon Stock | 2,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000008 · wf-form4_161308189860018.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,806 F2 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 9, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:18 UTC |
Knightly Kevin CSee Remarks
|
GrantCommon Stock | 9,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000008 · wf-form4_161308189860018.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,800 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 8, 2018. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2021. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:19 UTC |
Korakis Emmanuel NSr. Vice President, Controller
|
GrantStock Appreciation Right · Derivative | 2,670 | $0.00 Strike: $183.82 | $0.00 |
DisclosureSEC source: 0001478242-21-000009 · wf-form4_161308197150537.xml · derivative · entry 4 Korakis Emmanuel N · CIK 0001449366 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,670 Underlying: Common Stock · 2,670 shares Expires 2031-02-09 F3 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:19 UTC |
Korakis Emmanuel NSr. Vice President, Controller
|
Tax withholdingCommon Stock | 565 | $183.82 | $103,858.30 |
DisclosureSEC source: 0001478242-21-000009 · wf-form4_161308197150537.xml · nonDerivative · entry 3 Korakis Emmanuel N · CIK 0001449366 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,282 Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:19 UTC |
Korakis Emmanuel NSr. Vice President, Controller
|
GrantCommon Stock | 668 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000009 · wf-form4_161308197150537.xml · nonDerivative · entry 2 Korakis Emmanuel N · CIK 0001449366 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,847 F2 · shares: Represents a grant of restricted stock units that will vest in three annual installments beginning on February 9, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:19 UTC |
Korakis Emmanuel NSr. Vice President, Controller
|
GrantCommon Stock | 1,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000009 · wf-form4_161308197150537.xml · nonDerivative · entry 1 Korakis Emmanuel N · CIK 0001449366 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,179 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 8, 2018. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 9, 2021. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:17 UTC |
Bruehlman Ronald ESee Remarks
|
GrantStock Appreciation Right · Derivative | 26,701 | $0.00 Strike: $183.82 | $0.00 |
DisclosureSEC source: 0001478242-21-000007 · wf-form4_161308182421437.xml · derivative · entry 3 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,701 Underlying: Common Stock · 26,701 shares Expires 2031-02-09 F2 · derivative.exercise_date: This stock appreciation right vests in three annual installments beginning on February 9, 2022. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 22:17 UTC |
Bruehlman Ronald ESee Remarks
|
GrantCommon Stock | 6,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000007 · wf-form4_161308182421437.xml · nonDerivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,438 Read SEC document |
| February 09, 2021 Filed Dec 23, 2021 22:14 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 149 | $183.82 | $27,389.18 |
DisclosureSEC source: 0001478242-21-000064 · wf-form4_164029764106187.xml · derivative · entry 3 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149 Underlying: Common Stock · 149 shares Expires not disclosed F4 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F4 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F4 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 09, 2021 Filed Feb 2, 2022 22:01 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 156 | $183.82 | $28,675.92 |
DisclosureSEC source: 0001478242-22-000005 · wf-form5_164383923231572.xml · derivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,740 Underlying: Common Stock · 156 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 22:17 UTC |
BOUSBIB ARIDirector · See Remarks
|
Tax withholdingCommon Stock | 61,522 | $184.41 | $11,345,272.02 |
DisclosureSEC source: 0001478242-21-000003 · wf-form4_161247699990761.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 590,513 Read SEC document |
| December 24, 2020 Filed Dec 28, 2020 22:07 UTC |
DANHAKL JOHN GDirector
|
GiftCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-20-000082 · wf-form4_160919322114172.xml · nonDerivative · entry 2 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 37,410 F2 · price: The shares were donated to the Danhakl Family Foundation for no remuneration. F1 · ownership.nature: Shares held in the Danhakl Revocable Family Trust. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 22:07 UTC |
DANHAKL JOHN GDirector
|
PurchaseCommon Stock | 63,451 | $176.95 | $11,227,654.45 |
DisclosureSEC source: 0001478242-20-000082 · wf-form4_160919322114172.xml · nonDerivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 137,410 F1 · ownership.nature: Shares held in the Danhakl Revocable Family Trust. Read SEC document |
| December 10, 2020 Filed Feb 4, 2021 22:18 UTC |
Bruehlman Ronald ESee Remarks
|
GiftCommon Stock | 60 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000004 · wf-form5_161247709071920.xml · nonDerivative · entry 2 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,631 Read SEC document |
| December 09, 2020 Filed Feb 4, 2021 22:18 UTC |
Bruehlman Ronald ESee Remarks
|
GiftCommon Stock | 60 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-21-000004 · wf-form5_161247709071920.xml · nonDerivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,691 Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 22:03 UTC |
Rittenmeyer Ronald ADirector
|
SaleCommon Stock | 9,590 | $172.96 | $1,658,686.40 |
DisclosureSEC source: 0001478242-20-000080 · wf-form4_160634180732809.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,894 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $172.62 to $173.25 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 22:03 UTC |
Rittenmeyer Ronald ADirector
|
SaleCommon Stock | 40,792 | $174.35 | $7,112,085.20 |
DisclosureSEC source: 0001478242-20-000079 · wf-form4_160573697729958.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,484 F1 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $174.01 to $174.79 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 28, 2020 Filed Oct 30, 2020 21:00 UTC |
Korakis Emmanuel NSr. Vice President, Controller
|
GrantCommon Stock | 1,605 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-20-000077 · wf-form4_160409161420470.xml · nonDerivative · entry 1 Korakis Emmanuel N · CIK 0001449366 · Sr. Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,605 F1 · shares: Represents a grant of restricted stock units that will vest 100% on the third anniversary of the date of grant. Read SEC document |
| October 28, 2020 Filed Feb 4, 2021 22:23 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 185 | $155.71 | $28,806.35 |
DisclosureSEC source: 0001478242-21-000005 · wf-form5_161247740132282.xml · derivative · entry 4 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,584 Underlying: Common Stock · 185 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| October 12, 2020 Filed Oct 14, 2020 21:05 UTC |
BOUSBIB ARIDirector · See Remarks
|
OtherEmployee Stock Option (Right to Buy) · Derivative | 69,120 | $0.00 Strike: $8.34 | $0.00 |
DisclosureSEC source: 0001478242-20-000070 · wf-form4_160270952064808.xml · derivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 69,120 shares Expires 2020-12-01 Read SEC document |
| October 12, 2020 Filed Oct 14, 2020 21:05 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 69,120 | $170.00 | $11,750,400.00 |
DisclosureSEC source: 0001478242-20-000070 · wf-form4_160270952064808.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 652,035 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2020. Read SEC document |
| October 12, 2020 Filed Oct 14, 2020 21:05 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantCommon Stock | 69,120 | $8.34 | $576,460.80 |
DisclosureSEC source: 0001478242-20-000070 · wf-form4_160270952064808.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 721,155 Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 21:06 UTC |
BOUSBIB ARIDirector · See Remarks
|
OtherEmployee Stock Option (Right to Buy) · Derivative | 46,080 | $0.00 Strike: $8.34 | $0.00 |
DisclosureSEC source: 0001478242-20-000068 · wf-form4_160037675624374.xml · derivative · entry 4 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,120 Underlying: Common Stock · 46,080 shares Expires 2020-12-01 Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 21:06 UTC |
BOUSBIB ARIDirector · See Remarks
|
SaleCommon Stock | 46,080 | $164.36 | $7,573,708.80 |
DisclosureSEC source: 0001478242-20-000068 · wf-form4_160037675624374.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 652,035 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 18, 2020. F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $162.73 to $164.90 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 21:06 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantCommon Stock | 46,080 | $8.34 | $384,307.20 |
DisclosureSEC source: 0001478242-20-000068 · wf-form4_160037675624374.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 698,115 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.